<p><strong>INVO 的威斯康星州诊所现已成为 Progyny 会员的网络内诊所，扩大了诊所的市场覆盖范围</strong></p>
<p>威斯康星州米德尔顿和佛罗里达州萨拉索塔，2026 年 3 月 3 日（全球新闻通讯社）-- INVO Fertility, Inc.（纳斯达克代码：IVF）（“INVO Fertility” 或 “公司”），是一家专注于通过建立、收购和运营生育诊所及相关业务和技术来扩大先进生殖治疗获取渠道的医疗服务生育公司，今天宣布其威斯康星生育研究所（WFI）诊所已加入 Progyny 网络。</p>
<p>Progyny 通过全国 600 多家雇主和计划赞助商为约 720 万被覆盖人群提供生育和家庭建设福利。WFI 参与 Progyny 网络显著扩大了诊所对雇主赞助患者的获取渠道，并大幅增加了其在威斯康星州及周边地区的可服务市场。</p>
<p>符合条件的患者现在可以在网络内访问 WFI 提供的全面生殖服务，包括诊断测试、体外受精（IVF）、生育保存和其他先进治疗选项。Progyny 的临床整合福利设计简化了患者的财务和行政流程，降低了就医障碍，支持改善治疗利用率和结果。Progyny 已成为解决生育行业中最大患者挑战——获取和可负担性的重要力量。</p>
<p>从运营的角度来看，参与 Progyny 网络增强了 WFI 的第三方支付者组合，并扩大了其服务范围，能够为更多需要护理的患者提供服务。随着全国范围内雇主赞助的生育福利不断扩大，与领先的生育福利管理者建立合作关系对于推动有机增长变得越来越重要。</p>
<p>雇主赞助的生育福利是医疗福利中增长最快的领域之一，因为公司在争夺和留住人才方面竞争激烈。INVO Fertility 认为，通过全国认可的福利平台扩大获取渠道，增强了其竞争地位，并支持其在不断扩展的生育中心网络中的持续增长。公司将此视为一个重要的里程碑，对其更广泛的战略至关重要，旨在扩大其诊所平台，深化支付者关系，并增强长期财务表现。</p>
<p>“我们很高兴加入 Progyny 网络，作为生育福利的领导者，以其对透明度、卓越客户和会员满意度以及优越临床结果的承诺而闻名，” INVO Fertility 首席运营官 April McGhee 表示。“这一合作伙伴关系扩大了更多患者获得高质量生育治疗的渠道，同时强化了我们提供卓越成果和无缝、支持性护理体验的重点。我们期待帮助 Progyny 会员自信地建立家庭。”</p>
<p>“这一关系扩大了我们的可服务患者基础，并增强了我们对雇主赞助需求的获取，” INVO Fertility 首席执行官 Steve Shum 补充道。“随着我们通过战略诊所开发和收购继续增长，与像 Progyny 这样的领先福利提供者建立关系进一步增强了我们的增长目标、运营杠杆和为股东创造长期价值的能力。”</p>
<p><strong>关于 INVO Fertility</strong></p>
<p>我们是一家医疗服务生育公司，致力于为需要帮助的患者扩大辅助生殖技术（“ART”）护理。我们的主要商业战略专注于建立、收购和运营生育诊所，包括主要提供由我们的 INVOcell®医疗设备（“INVOcell”）支持的阴道内培养（“IVC”）程序的 “INVO 中心” 和美国本土盈利的体外受精（“IVF”）诊所。我们在美国拥有四家生育诊所。我们还继续参与将我们的 INVOcell 技术解决方案销售和分销到第三方拥有和运营的生育诊所。INVOcell 是一种专有且革命性的医疗设备，是首个允许受精和早期胚胎发育在女性体内进行的设备。IVC 程序为患者提供了比其他 ART 治疗更自然、更亲密和更实惠的体验。我们相信 IVC 程序可以以传统 IVF 成本的一小部分提供可比的结果，并且比宫内授精（“IUI”）是一种显著更有效的治疗。有关更多信息，请访问 www.invofertility.com。</p>
<p><strong>安全港声明</strong></p>
<p>本公告包含根据《1933 年证券法》第 27A 条和《1934 年证券交易法》第 21E 条的定义的前瞻性声明。公司援引 1995 年《私人证券诉讼改革法》的保护。所有关于我们预期未来财务状况、运营结果、现金流、融资计划、商业战略、产品和服务、竞争地位、增长机会、管理层未来运营计划和目标的声明，以及包含 “预期”、“如果”、“相信”、“计划”、“估计”、“期望”、“打算”、“可能”、“可以”、“应该”、“将” 等类似词语的声明均为前瞻性声明。所有前瞻性声明都涉及风险、不确定性和意外情况，其中许多超出我们的控制范围，这可能导致实际结果、表现或成就与预期结果、表现或成就存在重大差异。导致实际结果与前瞻性声明中的结果存在重大差异的因素包括我们在 www.sec.gov 上的文件中列出的因素。我们没有义务（并明确否认任何此类义务）更新或更改我们的前瞻性声明，无论是由于新信息、未来事件还是其他原因。</p>
<p><strong>如需更多信息，请联系：</strong></p>
<p><strong>INVO Fertility, Inc.</strong></p>
<p><strong>Steve Shum，首席执行官</strong></p>
<p>978-878-9505</p>
<p>sshum@invofertility.com</p>
<p><strong>投资者联系</strong></p>
<p><strong>Lytham Partners, LLC</strong></p>
<p><strong>Robert Blum</strong></p>
<p>602-889-9700</p>
<p>INVO@lythampartners.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk5EUXpOQ00zTkRVeU1EUTBJekl5T1RBNU9Eaz0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk5EUXpOQ00zTkRVeU1EUTBJekl5T1RBNU9Eaz0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjM4ZTQ2ZTMtZDljNi00YzEyLWEzZDgtOGYwNjI3MTQzZTAwLTEzMDI1MzktMjAyNi0wMy0wMy1lbg==/tiny/INVO-Fertility-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjM4ZTQ2ZTMtZDljNi00YzEyLWEzZDgtOGYwNjI3MTQzZTAwLTEzMDI1MzktMjAyNi0wMy0wMy1lbg==/tiny/INVO-Fertility-Inc-.png"/></p>

美国医疗保健供应商 ETF - iShares

标普医疗保健服务 ETF - SPDR

医疗业 ETF - SPDR

标普全球医疗股指数 ETF - iShares

PGNY

医疗业 ETF - Vanguard

<p>INVO Fertility 的威斯康星生育研究所已加入 Progyny 网络，增强了雇主赞助患者对生育服务的获取。这一合作伙伴关系扩大了 WFI 的市场覆盖范围，并改善了其支付方组合，符合对生育福利日益增长的需求。该合作旨在提供全面的生殖服务，包括试管婴儿和生育保存，同时支持 INVO Fertility 的增长战略和长期财务表现。首席运营官 April McGhee 和首席执行官 Steve Shum 强调了这一关系在推动有机增长和为患者提供高质量护理方面的重要性</p>

<p><strong>INVO’s Wisconsin Clinic is now in-network for Progyny members, expanding the clinic’s market reach</strong></p>
<div class="lb-trans"><p><strong>INVO 的威斯康星州诊所现已成为 Progyny 会员的网络内诊所，扩大了诊所的市场覆盖范围</strong></p>
</div><p>MIDDLETON, Wis. and SARASOTA, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that its Wisconsin Fertility Institute (WFI) clinic has joined the Progyny network.</p>
<div class="lb-trans"><p>威斯康星州米德尔顿和佛罗里达州萨拉索塔，2026 年 3 月 3 日（全球新闻通讯社）-- INVO Fertility, Inc.（纳斯达克代码：IVF）（“INVO Fertility” 或 “公司”），是一家专注于通过建立、收购和运营生育诊所及相关业务和技术来扩大先进生殖治疗获取渠道的医疗服务生育公司，今天宣布其威斯康星生育研究所（WFI）诊所已加入 Progyny 网络。</p>
</div><p>Progyny provides fertility and family-building benefits to an estimated 7.2 million covered lives through over 600 employers and plan sponsors nationwide. WFI’s participation in the Progyny network significantly expands the clinic’s access to employer-sponsored patients and meaningfully increases its addressable market within Wisconsin and surrounding regions.</p>
<div class="lb-trans"><p>Progyny 通过全国 600 多家雇主和计划赞助商为约 720 万被覆盖人群提供生育和家庭建设福利。WFI 参与 Progyny 网络显著扩大了诊所对雇主赞助患者的获取渠道，并大幅增加了其在威斯康星州及周边地区的可服务市场。</p>
</div><p>Eligible patients now have in-network access to WFI’s comprehensive suite of reproductive services, including diagnostic testing, in vitro fertilization (IVF), fertility preservation, and other advanced treatment options. Progyny’s clinically integrated benefit design simplifies financial and administrative processes for patients, reducing barriers to care and supporting improved treatment utilization and outcomes. Progyny has become a major force in addressing the greatest patient challenges in the fertility industry—access and affordability.</p>
<div class="lb-trans"><p>符合条件的患者现在可以在网络内访问 WFI 提供的全面生殖服务，包括诊断测试、体外受精（IVF）、生育保存和其他先进治疗选项。Progyny 的临床整合福利设计简化了患者的财务和行政流程，降低了就医障碍，支持改善治疗利用率和结果。Progyny 已成为解决生育行业中最大患者挑战——获取和可负担性的重要力量。</p>
</div><p>From an operational standpoint, participation in the Progyny network enhances WFI’s third-party payor mix and expands its services to a potentially larger number of patients in need of care. As employer-sponsored fertility benefits continue to expand nationwide, alignment with leading fertility benefits managers is increasingly important to driving organic growth.</p>
<div class="lb-trans"><p>从运营的角度来看，参与 Progyny 网络增强了 WFI 的第三方支付者组合，并扩大了其服务范围，能够为更多需要护理的患者提供服务。随着全国范围内雇主赞助的生育福利不断扩大，与领先的生育福利管理者建立合作关系对于推动有机增长变得越来越重要。</p>
</div><p>Employer-sponsored fertility benefits are one of the fastest-growing segments within healthcare benefits as companies compete to attract and retain talent. INVO Fertility believes that expanding access through nationally recognized benefit platforms strengthens its competitive positioning and supports sustained growth across its expanding network of fertility centers. The Company views this as a major milestone and important to its broader strategy to scale its clinic platform, deepen payor relationships, and strengthen long-term financial performance.</p>
<div class="lb-trans"><p>雇主赞助的生育福利是医疗福利中增长最快的领域之一，因为公司在争夺和留住人才方面竞争激烈。INVO Fertility 认为，通过全国认可的福利平台扩大获取渠道，增强了其竞争地位，并支持其在不断扩展的生育中心网络中的持续增长。公司将此视为一个重要的里程碑，对其更广泛的战略至关重要，旨在扩大其诊所平台，深化支付者关系，并增强长期财务表现。</p>
</div><p>“We are excited to join the Progyny network, a leader in fertility benefits known for its commitment to transparency, exceptional client and member satisfaction, and superior clinical outcomes,” said April McGhee, COO of INVO Fertility. “This partnership expands access to high-quality fertility treatment for more patients while reinforcing our focus on delivering exceptional results and a seamless, supportive care experience. We look forward to helping Progyny members build their families with confidence.”</p>
<div class="lb-trans"><p>“我们很高兴加入 Progyny 网络，作为生育福利的领导者，以其对透明度、卓越客户和会员满意度以及优越临床结果的承诺而闻名，” INVO Fertility 首席运营官 April McGhee 表示。“这一合作伙伴关系扩大了更多患者获得高质量生育治疗的渠道，同时强化了我们提供卓越成果和无缝、支持性护理体验的重点。我们期待帮助 Progyny 会员自信地建立家庭。”</p>
</div><p>“This relationship expands our addressable patient base and strengthens our access to employer-sponsored demand” added Steve Shum, CEO of INVO Fertility. “As we continue to grow through strategic clinic development and acquisitions, establishing relationships with leading benefits providers like Progyny represents a further enhancement to our growth objectives, operating leverage, and ability to drive long-term value creation for our shareholders.”</p>
<div class="lb-trans"><p>“这一关系扩大了我们的可服务患者基础，并增强了我们对雇主赞助需求的获取，” INVO Fertility 首席执行官 Steve Shum 补充道。“随着我们通过战略诊所开发和收购继续增长，与像 Progyny 这样的领先福利提供者建立关系进一步增强了我们的增长目标、运营杠杆和为股东创造长期价值的能力。”</p>
</div><p><strong>About INVO Fertility</strong></p>
<div class="lb-trans"><p><strong>关于 INVO Fertility</strong></p>
</div><p>We are a healthcare services fertility company dedicated to expanding assisted reproductive technology (” ART”) care to patients in need. Our principal commercial strategy is focused on building, acquiring and operating fertility clinics, including “INVO Centers” dedicated primarily to offering the intravaginal culture (“IVC”) procedure enabled by our INVOcell® medical device (“INVOcell”) and US-based, profitable in vitro fertilization (“IVF”) clinics. We have four fertility clinics in the United States. We also continue to engage in the sale and distribution of our INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more natural, intimate, and affordable experience in comparison to other ART treatments. We believe the IVC procedure can deliver comparable results at a fraction of the cost of traditional IVF and is a significantly more effective treatment than intrauterine insemination (“IUI”). For more information, please visit www.invofertility.com.</p>
<div class="lb-trans"><p>我们是一家医疗服务生育公司，致力于为需要帮助的患者扩大辅助生殖技术（“ART”）护理。我们的主要商业战略专注于建立、收购和运营生育诊所，包括主要提供由我们的 INVOcell®医疗设备（“INVOcell”）支持的阴道内培养（“IVC”）程序的 “INVO 中心” 和美国本土盈利的体外受精（“IVF”）诊所。我们在美国拥有四家生育诊所。我们还继续参与将我们的 INVOcell 技术解决方案销售和分销到第三方拥有和运营的生育诊所。INVOcell 是一种专有且革命性的医疗设备，是首个允许受精和早期胚胎发育在女性体内进行的设备。IVC 程序为患者提供了比其他 ART 治疗更自然、更亲密和更实惠的体验。我们相信 IVC 程序可以以传统 IVF 成本的一小部分提供可比的结果，并且比宫内授精（“IUI”）是一种显著更有效的治疗。有关更多信息，请访问 www.invofertility.com。</p>
</div><p><strong>Safe Harbor Statement</strong></p>
<div class="lb-trans"><p><strong>安全港声明</strong></p>
</div><p>This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events, or otherwise.</p>
<div class="lb-trans"><p>本公告包含根据《1933 年证券法》第 27A 条和《1934 年证券交易法》第 21E 条的定义的前瞻性声明。公司援引 1995 年《私人证券诉讼改革法》的保护。所有关于我们预期未来财务状况、运营结果、现金流、融资计划、商业战略、产品和服务、竞争地位、增长机会、管理层未来运营计划和目标的声明，以及包含 “预期”、“如果”、“相信”、“计划”、“估计”、“期望”、“打算”、“可能”、“可以”、“应该”、“将” 等类似词语的声明均为前瞻性声明。所有前瞻性声明都涉及风险、不确定性和意外情况，其中许多超出我们的控制范围，这可能导致实际结果、表现或成就与预期结果、表现或成就存在重大差异。导致实际结果与前瞻性声明中的结果存在重大差异的因素包括我们在 www.sec.gov 上的文件中列出的因素。我们没有义务（并明确否认任何此类义务）更新或更改我们的前瞻性声明，无论是由于新信息、未来事件还是其他原因。</p>
</div><p><strong>For more information, please contact:</strong></p>
<div class="lb-trans"><p><strong>如需更多信息，请联系：</strong></p>
</div><p><strong>INVO Fertility, Inc.</strong></p>
<div class="lb-trans"><p><strong>INVO Fertility, Inc.</strong></p>
</div><p><strong>Steve Shum, CEO</strong></p>
<div class="lb-trans"><p><strong>Steve Shum，首席执行官</strong></p>
</div><p>978-878-9505</p>
<div class="lb-trans"><p>978-878-9505</p>
</div><p>sshum@invofertility.com</p>
<div class="lb-trans"><p>sshum@invofertility.com</p>
</div><p><strong>Investor Contact</strong></p>
<div class="lb-trans"><p><strong>投资者联系</strong></p>
</div><p><strong>Lytham Partners, LLC</strong></p>
<div class="lb-trans"><p><strong>Lytham Partners, LLC</strong></p>
</div><p><strong>Robert Blum</strong></p>
<div class="lb-trans"><p><strong>Robert Blum</strong></p>
</div><p>602-889-9700</p>
<div class="lb-trans"><p>602-889-9700</p>
</div><p>INVO@lythampartners.com</p>
<div class="lb-trans"><p>INVO@lythampartners.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk5EUXpOQ00zTkRVeU1EUTBJekl5T1RBNU9Eaz0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTY2NDQzNCM3NDUyMDQ0IzIyOTA5ODk="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjM4ZTQ2ZTMtZDljNi00YzEyLWEzZDgtOGYwNjI3MTQzZTAwLTEzMDI1MzktMjAyNi0wMy0wMy1lbg==/tiny/INVO-Fertility-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/NjM4ZTQ2ZTMtZDljNi00YzEyLWEzZDgtOGYwNjI3MTQzZTAwLTEzMDI1MzktMjAyNi0wMy0wMy1lbg==/tiny/INVO-Fertility-Inc-.png"/></p>

INVO Fertility 的威斯康星诊所加入 Progyny 网络 | IVF 股票新闻